Latest Regulatory News

Page 134 of 807
Next Science Limited has updated the payment date for its cash return of capital to 10 February 2026, following its recent asset sale and pending ASX delisting.
Ada Torres
Ada Torres
30 Jan 2026
Golden Cross Resources reported a quiet December quarter with ongoing preparatory work at its flagship Copper Hill copper-gold project, while its ASX securities remain suspended pending operational compliance.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Iron Bear Resources has strengthened its financial position with fresh funding from Vale and a significant share sale, while progressing its flagship iron ore project in Canada amid positive government engagement.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Emperor Energy has appointed Tim Handley as Managing Director and is making significant progress on funding and preparing the Judith-2 appraisal well in the Offshore Gippsland Basin.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Triton Minerals has executed a key agreement advancing the sale of 70% of its Mozambique graphite assets and completed initial drilling at its Aucu gold-copper project, positioning the company for growth amid stable operating conditions.
Maxwell Dee
Maxwell Dee
30 Jan 2026
American Tungsten & Antimony Ltd (ASX, AT4) has initiated drilling at its Utah antimony project and expanded its Nevada tungsten portfolio, while preparing a spin-out IPO of Australian assets to sharpen its US focus.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Income Asset Management Group reveals a challenging Q2 FY2026 marked by a significant fraud event, resulting in losses and a strategic debt raise to shore up liquidity. Despite setbacks, client relationships remain intact as the group navigates legal and regulatory hurdles.
Claire Turing
Claire Turing
30 Jan 2026
European Lithium Limited has bolstered its cash reserves with over A$300 million from share sales in Critical Metals Corp, while delivering promising high-grade rare earth drilling results at its Greenland Tanbreez Project.
Maxwell Dee
Maxwell Dee
30 Jan 2026
EVE Health Group has transitioned from development to commercial rollout, delivering first patient prescriptions of Dyspro™ and completing initial manufacturing of Libbo™, supported by a $1.1 million capital raise.
Ada Torres
Ada Torres
30 Jan 2026
InFocus Group Holdings Limited has formalised its strategic expansion into iGaming and digital assets, appointing a high-profile advisory board and strengthening its capital position through convertible notes and Bitcoin ETF investments.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Sabre Resources reports significant rare earth, critical metals, and uranium anomalies from its Northern Territory projects, advancing plans for targeted drilling while maintaining a strong cash position.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Accent Resources NL reports steady progress on its Magnetite Range Project pre-feasibility study, confirming high-grade magnetite concentrate, while maintaining stable gold resources at Norseman and holding nearly $10 million in cash.
Maxwell Dee
Maxwell Dee
30 Jan 2026